この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
規制と法律 · 1995/12/191 分で読めます
Bioetica, Inc.; Premarket Approval of HEMOSTAGENERegister Absorbable Collagen Hemostatic Sponge
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its approval of the application by Bioetica, Inc., Westbrook, ME, on behalf of Coletica, S. A., Lyon, France, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of HEMOSTAGENE Absorbable Collagen Hemostatic Sponge. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of August 15, 1995, of the approval of the application.
情報源の原言語: Federal Register — All Documents原文の発表を開く →